Paulo Caleb Junior Lima Santos Selected Research

Paulo Caleb Junior Lima Santos Research Topics

3	Hemochromatosis (Bronze Diabetes) 11/2022 - 01/2018
3	Atrial Fibrillation 05/2021 - 08/2016
3	Hemorrhage 05/2021 - 04/2014
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2015 - 03/2012
2	Iron Overload 10/2022 - 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2022
1	hereditary Hyperferritinemia with congenital cataracts 01/2022
1	Dementia (Dementias) 12/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Stroke (Strokes) 08/2016
1	Polycythemia (Erythrocytosis) 01/2013
1	Myalgia 03/2012

4	Warfarin (Coumadin)FDA LinkGeneric 05/2021 - 08/2016
3	IronIBA 11/2022 - 01/2018
2	HepcidinsIBA 11/2022 - 10/2022
2	LDL Receptors (LDL Receptor)IBA 01/2015 - 03/2014
1	ApoferritinsIBA 01/2022
1	ElementsIBA 01/2022
1	5' Untranslated Regions (5' UTR)IBA 01/2022
1	Estrogen ReceptorsIBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	DiureticsIBA 01/2020
1	Bone Morphogenetic Protein 6IBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	AnticoagulantsIBA 08/2016
1	Amiodarone (Amiodarona)FDA LinkGeneric 04/2014
1	LipidsIBA 03/2014
1	Hemoglobins (Hemoglobin)IBA 01/2013
1	Oxygen (Dioxygen)IBA 01/2013
1	Erythropoietin FDA Link 01/2013
1	Creatine Kinase (Creatine Phosphokinase)IBA 03/2012
1	Atorvastatin (Lipitor)FDA Link 03/2012

4	Therapeutics 05/2021 - 03/2014
1	Aftercare (After-Treatment) 10/2022